September 17-19, 2018
Ocean Place Resort, Long Branch, NJ

> 2017 Exhibitors

> 2016 Exhibitors

> 2014 Exhibitors

Download Exhibitor Manual

Download Exhibitor Electric Form

ChemOutsourcing Banner To Alert Contacts You’re Attending

2018 Exhibitor List

read: buyers and suppliers together

Exhibitor List As Of July 16, 2018

Look for exhibitors according to their first letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

 

Patheon, A Division of Thermo Fisher
PharmaBlock
PMC Isochem
PolySciences, Inc.
Procos SpA

Patheon, A Division of Thermo Fisher

PharmaBlock

PharmaBlock R&D Co. Ltd. specializes in the development of innovative druglike scaffolds and building blocks. We provide world-class quality chemistry services including custom synthesis, lead generation/optimization and process development. We currently have 80 chemists including several Ph.D.s from US. Our laboratories are well equipped with the state-of-the-art instruments such as Biotage microwave synthesizers, Bruker 400 MHz NMR and Agilent 1200 LC/MS. Our goal is to help our customers acceler

PMC Isochem

PolySciences, Inc.

Procos SpA [ company website ]

Procos S.p.A., established in 1945, is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd. Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (API’s), High Potency Active Pharmaceutical Ingredients (HPAPI’s) for oncology, advanced intermediates and related services for the pharmaceutical industry.

Our core business sectors include custom synthesis and Generic API manufacturing. The manufacturing site is located in Cameri, Italy. The 110,000 square meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA. To ensure our constant growth in an increasingly competitive market, Procos strives to pursue new innovation, while keeping our core identity, by constantly investing in our company and in our people.